CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,346 | $587.34 | $791K | 47,987 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,790 | $588.33 | $1.1M | 46,197 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,734 | $589.18 | $1.0M | 44,463 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,068 | $590.32 | $630K | 43,395 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −602 | $591.24 | $356K | 42,793 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $592.19 | $71K | 42,673 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $593.83 | $143K | 42,433 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $594.61 | $238K | 42,033 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $595.80 | $191K | 41,713 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −319 | $596.87 | $190K | 41,394 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −201 | $598.52 | $120K | 41,193 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $599.48 | $168K | 40,913 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −182 | $600.52 | $109K | 40,731 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −98 | $601.57 | $59K | 40,633 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $602.72 | $72K | 40,513 |
| 2026-03-30 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 40,500 | ||
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −397 | $522.10 | $207K | 49,616 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,514 | $522.98 | $792K | 48,102 |
| 2026-03-27 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,809 | $523.88 | $948K | 46,293 |
Page 137 of 171 · 3,408 trades